Patenting Inventions and New Drugs in Pharmaceutical Industry

In the field of Pharma Industry, Patent Protection refers to the exclusive rights granted to the owner of the Patent for his invention that is given by the Patent Office to the Patentee or Patent Owner. As per the provision of the Patent Act, Patent means a Patent for any invention granted under the Act, whereas invention refers to a new product or process involving an inventive step and capable of industrial application; wherein Inventive Step means a feature of an invention that involves technical advance as compared to the existing knowledge or having economic significance or both and that makes the invention not obvious to a person skilled in the art. Therefore, a new chemical composition or drug, which has the inventive step, qualifies the criteria for being Patent which further turns into the Patent and provide the Patentee exclusive rights over that drug in terms of its manufacturing process, selling process and commercialization. Normally, the Patent is granted for twenty years which is called its term, and for that twenty years, Patentee enjoys exclusive rights over the patented drug which protects him from copying, manufacturing, selling & commercializing by others that gives him maximum profit as he deserve and desire unlike the other non-patented drug owner. A natural person, firm, company or any other legal entity can have the Patent Protection if they invent any new drug which qualifies the above criterion. Once, the term of the Patent expires, the Patent becomes the public property which can be enjoyed by public at large as it breaks its boundaries.

Patent Protection can obviously be noteworthy for Pharma Manufacturers, since it has important role in the value, goodwill, profit making capacity, strength & leadership qualities of the pharma manufacturers. The reason, non patented drugs remain in the public domain and can be manufactured by anybody so face huge competition in the market which result in limited profit making outcomes, however patented drugs face limited competition due to their exclusive qualities.

Due to the Patent Protection given to the drugs, Pharma Manufacturers have the important roles of the players in the market since the patented drugs due to the Patent Protection have the qualities to bring the revolution in the market for the consumers, manufacturers as well as pharma industry.

Therefore, it is concluded that Patent Protection is a noteworthy aspect of the Parma Industry which does not only confer the profit maximization opportunities; it provides multiple specific recognitions also to the Pharma Manufacturers.

Aliya Rizvi
Attorney of, LEX INTELLI
Email : lexintellilaw@gmail.com

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit